Annals of Clinical Neurophysiology

  • 제23권2호
  • /
  • Pages.117-120
  • /
  • 2021
  • /
  • 2508-691X(pISSN)
  • /
  • 2508-6960(eISSN)
대한임상신경생리학회 (The Korean Society of Clinical Neurophysiology)
권호 표지
DOI QR코드

DOI QR Code

Autonomic instability in severe tetanus: a case report

  • Seo, Seung Won (Department of Neurology, Kosin University College of Medicine) ;
  • Lee, Jaewon (Department of Neurology, Kosin University College of Medicine) ;
  • Yoo, Bong-Goo (Department of Neurology, Kosin University College of Medicine) ;
  • Kim, Jehun (Department of Pulmonary and Critical Care Medicine, Kosin University College of Medicine) ;
  • Huh, So-Young (Department of Neurology, Kosin University College of Medicine)
  • 투고 : 2021.06.04
  • 심사 : 2021.07.21
  • 발행 : 2021.10.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Tetanus is an infectious disease of the nervous system caused by Clostridium tetani, and is characterized by tonic muscle contractions, painful spasms, and autonomic dysfunction. Severe autonomic dysfunction associated with tetanus can be life-threatening. We present a 62-year-old female who experienced lockjaw after an ankle fracture. The patient was diagnosed with tetanus and received tetanus immunoglobulin and a vaccination. The patient subsequently experienced labile hypertension. This case highlights the challenge and importance of managing cardiovascular instability.

키워드

참고문헌

  1. Berkowitz AL. Tetanus, botulism, and diphtheria. Continuum (Minneap Minn) 2018;24:1459-1488. https://doi.org/10.1212/con.0000000000000651
  2. Wasay M, Khealani BA, Talati N, Shamsi R, Syed NA, Salahuddin N. Autonomic nervous system dysfunction predicts poor prognosis in patients with mild to moderate tetanus. BMC Neurol 2005;5:2. https://doi.org/10.1186/1471-2377-5-2
  3. Anuradha S. Tetanus in adults--a continuing problem: an analysis of 217 patients over 3 years from Delhi, India, with special emphasis on predictors of mortality. Med J Malaysia 2006;61:7-14.
  4. Korea Disease Control and Prevention Agency. Infectious disease portal report [Internet]. Cheongju, Korea: Korea Disease Control and Prevention Agency; c2021 [accessed 2021 Mar 15]. Available from: http://www.kdca.go.kr/npt/biz/npp/ist/simple/simplePd-StatsMain.do
  5. Abrutyn E. Tetanus. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's principle's of internal medicine. 17th ed. New York: Mc Graw Hill Inc., 2008;898-900.
  6. Spruyt GM, Van Den Heever T. The treatment of autonomic dysfunction in tetanus. South Afr J Crit Care 2017;33:28-31.
  7. Farrar JJ, Yen LM, Cook T, Fairweather N, Binh N, Parry J, et al. Tetanus. J Neurol Neurosurg Psychiatry 2000;69:292-301. https://doi.org/10.1136/jnnp.69.3.292
  8. Rodrigo C, Fernando D, Rajapakse S. Pharmacological management of tetanus: an evidence-based review. Crit Care 2014;18:217. https://doi.org/10.1186/cc13797
  9. Dundee JW, Morrow WF. Labetalol in severe tetanus. Br Med J 1979;1:1121-1122. https://doi.org/10.1136/bmj.1.6171.1121
  10. Wesley AG, Hariparsad D, Pather M, Rocke DA. Labetalol in tetanus. The treatment of sympathetic nervous system overactivity. Anaesthesia 1983;38:243-249.